Who invested in X4 Pharmaceuticals?
X4 Pharmaceuticals's investors include New Enterprise Associates, OrbiMed, Cormorant Asset Management, Hercules Capital and SV Health Investors, and 1 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$193Mraised across 2 rounds since 2015, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $85M sold, first sale Aug 2025
No investor was named in the report.
From a historical funding recordSEC filing: $37M sold, first sale Aug 2015
From X4 Pharmaceuticals's own website: 3 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
X4 Pharmaceuticals's investors include New Enterprise Associates, OrbiMed, Cormorant Asset Management, Hercules Capital and SV Health Investors, and 1 more on record.
X4 Pharmaceuticals has raised $193M across 2 rounds since 2015.
X4 Pharmaceuticals's most recent round was an Undisclosed round of $155M in Oct 2025.
Its most recent round, $155M in Oct 2025, is also its largest on record.
X4 Pharmaceuticals's first round on record, in Oct 2025, was backed by New Enterprise Associates, OrbiMed and Cormorant Asset Management and 3 others.
X4 Pharmaceuticals's latest named round is an Undisclosed round, in Oct 2025.
X4 Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.